HHM Wealth Advisors’s BriaCell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCTX
HHM Wealth Advisors's BCTX Position: Q3 2026 in Review
HHM Wealth Advisors held its BriaCell Therapeutics (BCTX) position steady in Q3 2026 at 6 shares worth $26. The position accounts for ﹤0.01% of the portfolio, ranked #958.
HHM Wealth Advisors first reported a position in BCTX in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.24K in Q3 2024. 19 funds tracked by Wall St. Rank hold BCTX as of Q3 2026.
- HHM Wealth Advisors held 6 shares of BriaCell Therapeutics worth $26 as of Q3 2026.
- HHM Wealth Advisors left its BriaCell Therapeutics share count unchanged in Q3 2026.
- BriaCell Therapeutics made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q3 2026, its #958 holding.
- HHM Wealth Advisors first reported a position in BriaCell Therapeutics in Q2 2024 and has held it in 10 quarters since.
- HHM Wealth Advisors's BriaCell Therapeutics position peaked at $1.24K in Q3 2024.
- 19 funds tracked by Wall St. Rank held BriaCell Therapeutics as of Q3 2026.
Based on HHM Wealth Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.